Stay updated with breaking news from Jeff Baxter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PreHevbri® is the only approved 3-antigen hepatitis B vaccine for adults in the Netherlands and Belgium Product to be launched via marketing and distribution partner, Valneva
Brii Biosciences has acquired worldwide exclusive license to VBI-2601 and an exclusive license for PreHevbri® in the Asia Pacific region VBI will receive gross proceeds of $15 million in upfront payments, subject to near-term milestone achievements, including an equity investment of approximately $3 million VBI is eligible to receive up to $422 million in additional potential regulatory and commercial milestone payments, plus double-digit royalties
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul 5, 2023--
PreHevbri® is the only approved 3-antigen hepatitis B vaccine for adults in the U.K. Product to be launched via marketing and distribution partner, Valneva ... | June 15, 2023
Patrick Simmons discussed the Doobie Brothers' updated 50th-anniversary tour set list in an exclusive June 2023 interview.